To include your compound in the COVID-19 Resource Center, submit it here.

T64 lometrexol: TLRK said it discontinued development of T64 in order focus its clinical efforts. The company said it decided not to invest additional resources

Tularik Inc. (TLRK), South San Francisco, Calif.
Product: T64 lometrexol
Business:

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE